- Home
- ABUS vs VREX Comparison
ABUS vs VREX Comparison
Compare ABUS & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- VREX
- Stock Information
- Founded
- ABUS N/A
- VREX 2016
- Country
- ABUS United States
- VREX United States
- Employees
- ABUS N/A
- VREX N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- VREX Industrial Machinery/Components
- Sector
- ABUS Health Care
- VREX Technology
- Exchange
- ABUS Nasdaq
- VREX Nasdaq
- Market Cap
- ABUS 617.3M
- VREX 576.8M
- IPO Year
- ABUS N/A
- VREX N/A
- Fundamental
- Price
- ABUS $3.51
- VREX $11.43
- Analyst Decision
- ABUS Strong Buy
- VREX Strong Buy
- Analyst Count
- ABUS 4
- VREX 2
- Target Price
- ABUS $5.50
- VREX $22.50
- AVG Volume (30 Days)
- ABUS 1.0M
- VREX 316.9K
- Earning Date
- ABUS 03-27-2025
- VREX 05-01-2025
- Dividend Yield
- ABUS N/A
- VREX N/A
- EPS Growth
- ABUS N/A
- VREX N/A
- EPS
- ABUS N/A
- VREX N/A
- Revenue
- ABUS $6,171,000.00
- VREX $820,800,000.00
- Revenue This Year
- ABUS N/A
- VREX $4.03
- Revenue Next Year
- ABUS $61.99
- VREX $3.32
- P/E Ratio
- ABUS N/A
- VREX N/A
- Revenue Growth
- ABUS N/A
- VREX N/A
- 52 Week Low
- ABUS $2.30
- VREX $10.19
- 52 Week High
- ABUS $4.72
- VREX $18.30
- Technical
- Relative Strength Index (RSI)
- ABUS 58.89
- VREX 30.17
- Support Level
- ABUS $3.20
- VREX $12.40
- Resistance Level
- ABUS $3.45
- VREX $12.78
- Average True Range (ATR)
- ABUS 0.14
- VREX 0.38
- MACD
- ABUS 0.03
- VREX -0.10
- Stochastic Oscillator
- ABUS 78.65
- VREX 10.22
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.